Filter
390
Text search:
tb
coinfection
Featured
38
110
Language
Document type
282
41
34
10
10
5
4
3
1
Countries / Regions
18
17
15
14
10
9
8
8
7
7
6
6
6
6
6
6
5
5
5
4
4
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
146
48
6
4
3
3
2
Toolboxes
134
108
14
7
4
3
2
2
1
1
1
1
1
(Published with Decision No. 3003/QðBYT dated 19/8/2009 of the Minister of Health)
Настоящие руководящие принципы предназначены для специалистов, имеющих дело с теми потребителями наркотиков, которые применяют наиболее проблемные модели потре
...
Venturini et al. BMC Infectious Diseases 2014, 14(Suppl 1):S5 http://www.biomedcentral.com/1471-2334/14/S1/S5
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
Accessed: 24.09.2019
Accessed: 27.09.2019
Accessed: 29.09.2019
Accessed: 26.09.2019
Accessed: 26.09.2019
Accessed: 26.09.2019
Accessed: 04.10.2019
2018 Global HIV Statistics
SDG target 3.3: by 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, waterborne diseases and other communicable diseases.
1-13 December 2018 | Geneva, Switzerland UNAIDS Programme Coordinating Board Issue date: 23 November 2018
UNAIDS/PCB (43)/18.32
WHO Annual Meeting with Pharmaceutical Companies and Stakeholders
08 March 2016, Geneva
2015-06-03 - Board presentation - v32.pptx
Октябрь 2017
Русский
Рекомендации EACS 9.0